Brinker Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $2.26M | Sell |
7,794
-2,446
| -24% | -$710K | 0.07% | 262 |
|
|
2020
Q1 | $2.44M | Sell |
10,240
-1,684
| -14% | -$401K | 0.1% | 210 |
|
|
2019
Q4 | $2.61M | Sell |
11,924
-554
| -4% | -$121K | 0.08% | 243 |
|
|
2019
Q3 | $2.11M | Buy |
12,478
+11
| +0.1% | +$1.86K | 0.07% | 283 |
|
|
2019
Q2 | $2.29M | Sell |
12,467
-28
| -0.2% | -$5.13K | 0.08% | 239 |
|
|
2019
Q1 | $2.3M | Sell |
12,495
-2,456
| -16% | -$452K | 0.09% | 228 |
|
|
2018
Q4 | $2.48M | Sell |
14,951
-379
| -2% | -$62.8K | 0.11% | 180 |
|
|
2018
Q3 | $2.96M | Buy |
15,330
+162
| +1% | +$31.2K | 0.11% | 200 |
|
|
2018
Q2 | $2.58M | Buy |
15,168
+945
| +7% | +$161K | 0.1% | 218 |
|
|
2018
Q1 | $2.32M | Buy |
14,223
+3,468
| +32% | +$565K | 0.09% | 224 |
|
|
2017
Q4 | $1.61M | Buy |
10,755
+936
| +10% | +$140K | 0.06% | 291 |
|
|
2017
Q3 | $1.49M | Sell |
9,819
-2,413
| -20% | -$367K | 0.06% | 297 |
|
|
2017
Q2 | $1.58M | Sell |
12,232
-1,436
| -11% | -$185K | 0.07% | 273 |
|
|
2017
Q1 | $1.5M | Buy |
13,668
+1,791
| +15% | +$196K | 0.07% | 263 |
|
|
2016
Q4 | $875K | Buy |
11,877
+5,795
| +95% | +$427K | 0.05% | 325 |
|
|
2016
Q3 | $530K | Sell |
6,082
-900
| -13% | -$78.4K | 0.05% | 189 |
|
|
2016
Q2 | $601K | Buy |
6,982
+972
| +16% | +$83.7K | 0.05% | 156 |
|
|
2016
Q1 | $477K | Buy |
6,010
+2,691
| +81% | +$214K | 0.04% | 207 |
|
|
2015
Q4 | $418K | Buy |
+3,319
| New | +$418K | 0.03% | 157 |
|
|
2015
Q3 | – | Sell |
-10,639
| Closed | -$1.31M | – | 141 |
|
|
2015
Q2 | $1.31M | Buy |
+10,639
| New | +$1.31M | 0.11% | 65 |
|